Zhejiang HISUN Biomaterials Co. Ltd. A Total Assets
Zhejiang HISUN Biomaterials Co. Ltd. A total assets. Based on the latest financial reports, Zhejiang HISUN Biomaterials Co. Ltd. A (688203) holds total assets worth CN¥2.02 Billion CNY (≈ $295.59 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Zhejiang HISUN Biomaterials Co. Ltd. A market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
Total assets of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024. This chart illustrates how Zhejiang HISUN Biomaterials Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See 688203 live share price for real-time trading data and today's change.
Zhejiang HISUN Biomaterials Co. Ltd. A - Asset Composition Analysis
Zhejiang HISUN Biomaterials Co. Ltd. A Total Assets Breakdown (December 2024)
Zhejiang HISUN Biomaterials Co. Ltd. A total assets breakdown as of December 2024. Zhejiang HISUN Biomaterials Co. Ltd. A's total assets of CN¥2.02 Billion consist of 39.1% current assets and 60.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 25.0% |
| Accounts Receivable | CN¥53.81 Million | 2.6% |
| Inventory | CN¥160.52 Million | 7.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥75.58 Million | 3.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Zhejiang HISUN Biomaterials Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Zhejiang HISUN Biomaterials Co. Ltd. A current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang HISUN Biomaterials Co. Ltd. A's current assets represent 39.1% of total assets in 2024, a decrease from 59.5% in 2020.
- Cash Position: Cash and equivalents constituted 25.0% of total assets in 2024, down from 50.6% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 7.8% of total assets.
Zhejiang HISUN Biomaterials Co. Ltd. A Competitors by Total Assets
Key competitors of Zhejiang HISUN Biomaterials Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Rongsheng Petrochemical Co Ltd
SHE:002493
|
China | CN¥402.82 Billion |
|
Methanex Corporation
TO:MX
|
Canada | CA$7.17 Billion |
|
Sinofibers Technology Co Ltd
SHE:300777
|
China | CN¥4.94 Billion |
|
North Chemical Industries Co Ltd
SHE:002246
|
China | CN¥4.91 Billion |
|
Robertet SA
PA:RBT
|
France | €1.00 Billion |
|
Shanghai Pret Composites
SHE:002324
|
China | CN¥13.10 Billion |
|
Hangzhou Greenda Electronic Materials Co Ltd
SHG:603931
|
China | CN¥2.18 Billion |
|
Yunnan Yunwei Co Ltd Class A
SHG:600725
|
China | CN¥353.34 Million |
Zhejiang HISUN Biomaterials Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.69 | 1.99 | 3.08 |
| Quick Ratio | 1.28 | 1.62 | 2.73 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥309.44 Million | CN¥426.91 Million | CN¥726.11 Million |
Zhejiang HISUN Biomaterials Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Zhejiang HISUN Biomaterials Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 0.7% |
| Total Assets | CN¥2.07 Billion |
| Market Capitalization | $465.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang HISUN Biomaterials Co. Ltd. A's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang HISUN Biomaterials Co. Ltd. A's assets grew by 0.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
The table below shows the annual total assets of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.07 Billion ≈ $302.26 Million |
+0.74% |
| 2023-12-31 | CN¥2.05 Billion ≈ $300.06 Million |
+6.33% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.20 Million |
+62.98% |
| 2021-12-31 | CN¥1.18 Billion ≈ $173.15 Million |
+0.78% |
| 2020-12-31 | CN¥1.17 Billion ≈ $171.81 Million |
-- |
About Zhejiang HISUN Biomaterials Co. Ltd. A
Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film and laminating, injection molding, non-woven fabric, and injection blow molding. Zhejiang Hisun Biomaterials Co.Ltd. was founded in 2004 and is based in Taizhou, … Read more